Cargando…
A comparison of foamy and lentiviral vector genotoxicity in SCID-repopulating cells shows foamy vectors are less prone to clonal dominance
Hematopoietic stem cell (HSC) gene therapy using retroviral vectors has immense potential, but vector-mediated genotoxicity limits use in the clinic. Lentiviral vectors are less genotoxic than gammaretroviral vectors and have become the vector of choice in clinical trials. Foamy retroviral vectors h...
Autores principales: | Everson, Elizabeth M, Olzsko, Miles E, Leap, David J, Hocum, Jonah D, Trobridge, Grant D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4988344/ https://www.ncbi.nlm.nih.gov/pubmed/27579335 http://dx.doi.org/10.1038/mtm.2016.48 |
Ejemplares similares
-
Evidence for the in vivo safety of insulated foamy viral vectors
por: Browning, Diana L., et al.
Publicado: (2016) -
Retargeted Foamy Virus Vectors Integrate Less Frequently Near Proto-oncogenes
por: Hocum, Jonah D., et al.
Publicado: (2016) -
Foamy Virus Vectors for HIV Gene Therapy
por: Olszko, Miles E., et al.
Publicado: (2013) -
Prospects for Foamy Viral Vector Anti-HIV Gene Therapy
por: Nalla, Arun K., et al.
Publicado: (2016) -
High-titer foamy virus vector transduction and integration sites of human CD34(+) cell–derived SCID-repopulating cells
por: Nasimuzzaman, Md, et al.
Publicado: (2014)